Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study.

PLoS One · 2016 · PMC4859474 · PMID 27152598

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

approached significancep = 0.051so close (0.05 < p ≤ 0.1)

However, in our intention-to-treat analysis, the use of metformin in people prescribed insulin was still associated with a lower risk of all-cause mortality, and risk approached significance for the MACE endpoint (p = 0.051).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.